FY2018 Earnings Estimate for Acadia Healthcare Company Inc Issued By William Blair (ACHC)

Acadia Healthcare Company Inc (NASDAQ:ACHC) – Equities research analysts at William Blair decreased their FY2018 earnings per share (EPS) estimates for shares of Acadia Healthcare in a note issued to investors on Tuesday, November 6th. William Blair analyst R. Daniels now anticipates that the company will post earnings per share of $2.27 for the year, down from their previous forecast of $2.54. William Blair also issued estimates for Acadia Healthcare’s Q4 2019 earnings at $0.67 EPS and FY2019 earnings at $2.70 EPS.

Acadia Healthcare (NASDAQ:ACHC) last posted its earnings results on Monday, November 5th. The company reported $0.55 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.64 by ($0.09). Acadia Healthcare had a net margin of 7.43% and a return on equity of 7.74%. The business had revenue of $760.90 million during the quarter, compared to analyst estimates of $760.46 million. During the same period in the previous year, the firm posted $0.58 earnings per share. The firm’s revenue was up 6.2% on a year-over-year basis.

Several other research analysts have also recently weighed in on the company. BidaskClub cut Acadia Healthcare from a “buy” rating to a “hold” rating in a research report on Thursday, September 13th. ValuEngine cut Acadia Healthcare from a “sell” rating to a “strong sell” rating in a research report on Thursday, September 6th. Mizuho set a $37.00 price objective on Acadia Healthcare and gave the stock a “hold” rating in a research report on Tuesday, August 28th. Craig Hallum cut Acadia Healthcare from a “buy” rating to a “hold” rating in a research report on Wednesday, October 17th. They noted that the move was a valuation call. Finally, Cantor Fitzgerald reaffirmed a “hold” rating and set a $39.00 price objective on shares of Acadia Healthcare in a research report on Thursday, October 18th. Eight research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The stock has an average rating of “Hold” and a consensus target price of $43.11.

NASDAQ:ACHC opened at $41.72 on Wednesday. Acadia Healthcare has a 1 year low of $26.92 and a 1 year high of $45.35. The company has a quick ratio of 1.24, a current ratio of 1.24 and a debt-to-equity ratio of 1.20. The stock has a market capitalization of $3.44 billion, a price-to-earnings ratio of 18.14, a price-to-earnings-growth ratio of 1.52 and a beta of 0.22.

In other news, Director Reeve B. Waud sold 41,865 shares of the company’s stock in a transaction dated Thursday, November 1st. The stock was sold at an average price of $45.00, for a total transaction of $1,883,925.00. Following the completion of the transaction, the director now directly owns 14,213 shares of the company’s stock, valued at $639,585. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. 11.10% of the stock is owned by corporate insiders.

Several hedge funds have recently bought and sold shares of ACHC. State Treasurer State of Michigan boosted its position in Acadia Healthcare by 7.9% during the third quarter. State Treasurer State of Michigan now owns 32,600 shares of the company’s stock valued at $1,148,000 after purchasing an additional 2,400 shares during the last quarter. Public Employees Retirement System of Ohio boosted its position in Acadia Healthcare by 18.5% during the second quarter. Public Employees Retirement System of Ohio now owns 36,925 shares of the company’s stock valued at $1,511,000 after purchasing an additional 5,762 shares during the last quarter. Capital Fund Management S.A. acquired a new position in Acadia Healthcare during the second quarter valued at approximately $3,351,000. Envestnet Asset Management Inc. boosted its position in Acadia Healthcare by 6.1% during the second quarter. Envestnet Asset Management Inc. now owns 78,446 shares of the company’s stock valued at $3,209,000 after purchasing an additional 4,535 shares during the last quarter. Finally, Glenmede Trust Co. NA boosted its position in Acadia Healthcare by 4.1% during the second quarter. Glenmede Trust Co. NA now owns 1,028,476 shares of the company’s stock valued at $42,075,000 after purchasing an additional 40,147 shares during the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities. The company operates acute inpatient psychiatric facilities, which offer evaluation and crisis stabilization of patients with severe psychiatric diagnoses; specialty treatment facilities, including residential recovery facilities, eating disorder facilities, and comprehensive treatment centers that provide continuum care for adults with addictive disorders and co-occurring mental disorders; and residential treatment centers, which treat patients with behavioral disorders in a non-hospital setting, including outdoor programs.

See Also: What are the components of an earnings report?

Earnings History and Estimates for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply